Editas Medicine Inc (EDIT)
2.205
0.00 (0.00%)
USD |
NASDAQ |
Nov 27, 16:00
2.21
0.00 (0.00%)
After-Hours: 17:48
Editas Medicine Shares Outstanding: 82.55M for Oct. 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 30, 2024 | 82.55M |
September 30, 2024 | 82.54M |
August 02, 2024 | 82.48M |
June 30, 2024 | 82.43M |
May 03, 2024 | 82.24M |
April 02, 2024 | 82.23M |
March 31, 2024 | 82.24M |
February 23, 2024 | 81.81M |
December 31, 2023 | 81.77M |
October 27, 2023 | 81.67M |
September 30, 2023 | 81.67M |
July 28, 2023 | 81.63M |
June 30, 2023 | 81.62M |
June 20, 2023 | 81.53M |
May 31, 2023 | 69.03M |
April 28, 2023 | 69.00M |
April 04, 2023 | 68.99M |
March 31, 2023 | 68.99M |
February 17, 2023 | 68.97M |
December 31, 2022 | 68.85M |
October 28, 2022 | 68.76M |
September 30, 2022 | 68.76M |
July 29, 2022 | 68.74M |
June 30, 2022 | 68.72M |
April 29, 2022 | 68.64M |
Date | Value |
---|---|
April 12, 2022 | 68.64M |
March 31, 2022 | 68.60M |
February 14, 2022 | 68.52M |
December 31, 2021 | 68.44M |
November 05, 2021 | 68.40M |
September 30, 2021 | 68.32M |
July 30, 2021 | 68.26M |
June 30, 2021 | 68.16M |
April 30, 2021 | 67.83M |
April 06, 2021 | 67.58M |
March 31, 2021 | 67.47M |
February 14, 2021 | 67.36M |
January 25, 2021 | 66.37M |
January 11, 2021 | 62.87M |
December 31, 2020 | 62.56M |
October 30, 2020 | 62.33M |
September 30, 2020 | 62.19M |
July 31, 2020 | 62.27M |
June 30, 2020 | 62.10M |
June 26, 2020 | 61.95M |
May 31, 2020 | 55.05M |
May 01, 2020 | 54.82M |
April 30, 2020 | 54.82M |
April 15, 2020 | 54.98M |
April 01, 2020 | 54.98M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
54.36M
Minimum
Dec 31 2019
82.55M
Maximum
Oct 30 2024
69.15M
Average
68.60M
Median
Mar 31 2022
Shares Outstanding Benchmarks
Ionis Pharmaceuticals Inc | 157.90M |
EyePoint Pharmaceuticals Inc | 68.25M |
Cassava Sciences Inc | 48.11M |
Adverum Biotechnologies Inc | 20.80M |
Regenxbio Inc | 49.55M |